The 3D tissue microenvironment modulates DNA methylation and E-cadherin expression in squamous cell carcinoma

Epigenetics

Volumn 7, Issue 1, 2012, Pages 34-46

  desRochers, Teresa M ^a,b   Shamis, Yulia ^a,b   Alt Holland, Addy ^b   Kudo, Yasusei ^c   Takata, Takashi ^c   Wang, Guangwen ^d   Jackson Grusby, Laurie ^d   Garlick, Jonathan A ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY SCHOOL OF DENTAL MEDICINE   (United States)

^c HIROSHIMA UNIVERSITY   (Japan)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

DNA methylation; E cadherin; Epigenetics; Microenvironment; Squamous cell carcinoma

Indexed keywords

MICRORNA; UVOMORULIN;

ARTICLE; CANCER INVASION; CELL INTERACTION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; GENE CONTROL; HISTONE MODIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; PROMOTER REGION; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH;

EID: 84863040116     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.7.1.18546     Document Type: Article

References (60)

1. Andriani F, Garfield J, Fusenig NE, Garlick JA. Basement membrane proteins promote progression of intraepithelial neoplasia in 3-dimensional models of human stratified epithelium. Int J Cancer 2004; 108:348-57 PMID:14648700; http://dx.doi. org/10.1002/ijc.11525.
2. Margulis A, Zhang W, Alt-Holland A, Pawagi S, Prabhu P, Cao J, et al. Loss of intercellular adhesion activates a transition from low-to high-grade human squamous cell carcinoma. Int J Cancer 2006; 118:821-31 PMID:16152579; http://dx.doi.org/10.1002/ ijc.21409.
3. Itano N, Zhuo L, Kimata K. Impact of the hyaluronan-rich tumor microenvironment on cancer initiation and progression. Cancer Sci 2008; 99:1720-5 PMID:18564137; http://dx.doi.org/10.1111/j.1349-7006.2008.00885.x.
4. Li H, Fan X, Houghton J. Tumor microenvironment: the role of the tumor stroma in cancer. J Cell Biochem 2007; 101:805-15 PMID:17226777; http://dx.doi. org/10.1002/jcb.21159.
5. Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer 2001; 1:46-54 PMID:11900251; http:// dx.doi.org/10.1038/35094059.
6. Ziober AF, Falls EM, Ziober BL. The extracellular matrix in oral squamous cell carcinoma: friend or foe? Head Neck 2006; 28:740-9 PMID:16649214; http:// dx.doi.org/10.1002/hed.20382.
7. Gal-Yam EN, Egger G, Iniguez L, Holster H, Einarsson S, Zhang X, et al. Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line. Proc Natl Acad Sci USA 2008; 105:12979-84 PMID:18753622; http://dx.doi. org/10.1073/pnas.0806437105.
8. Graff JR, Gabrielson E, Fujii H, Baylin SB, Herman JG. Methylation patterns of the E-cadherin 5' CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chem 2000; 275:2727-32 PMID:10644736; http://dx.doi.org/10.1074/ jbc.275.4.2727.
9. Alt-Holland A, Shamis Y, Riley KN, DesRochers TM, Fusenig NE, Herman IM, et al. E-cadherin suppression directs cytoskeletal rearrangement and intraepithelial tumor cell migration in 3D human skin equivalents. J Invest Dermatol 2008; 128:2498-507 PMID:18528437; http://dx.doi.org/10.1038/ jid.2008.102.
10. Behrens J. The role of cell adhesion molecules in cancer invasion and metastasis. Breast Cancer Res Treat 1993; 24:175-84 PMID:8435473; http://dx.doi. org/10.1007/BF01833258.
11. Birchmeier W, Hulsken J, Behrens J. E-cadherin as an invasion suppressor. Ciba Found Symp 1995; 189:124-36 PMID:7587628.
12. Margulis A, Zhang W, Alt-Holland A, Crawford HC, Fusenig NE, Garlick JA. E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs. Cancer Res 2005; 65:1783-91 PMID:15753375; http://dx.doi. org/10.1158/0008-5472.CAN-04-3399.
13. Zschiesche W, Schonborn I, Behrens J, Herrenknecht K, Hartveit F, Lilleng P, et al. Expression of E-cadherin and catenins in invasive mammary carcinomas. Anticancer Res 1997; 17:561-7 PMID:9066580.
14. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 2010; 12:247-56 PMID:20173740.
15. Diniz-Freitas M, García-Caballero T, Antúnez-López J, Gándara-Rey JM, García-García A. Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma. Oral Oncol 2006; 42:190-200 PMID:16249116; http://dx.doi. org/10.1016/j.oraloncology.2005.07.010.
16. Supic G, Kozomara R, Brankovic-Magic M, Jovic N, Magic Z. Gene hypermethylation in tumor tissue of advanced oral squamous cell carcinoma patients. Oral Oncol 2009; 45:1051-7 PMID:19665921; http:// dx.doi.org/10.1016/j.oraloncology.2009.07.007.
17. Ha PK, Califano JA. Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma. Lancet Oncol 2006; 7:77-82 PMID:16389187; http://dx.doi.org/10.1016/S1470-2045(05)70540-4.
18. Hung KF, Chang CS, Liu CJ, Lui MT, Cheng CY, Kao SY. Differential expression of E-cadherin in metastatic lesions comparing to primary oral squamous cell carcinoma. J Oral Pathol Med 2006; 35:589-94 PMID:17032390; http://dx.doi.org/10.1111/j.1600-0714.2006.00474.x.
19. Caldeira JR, Prando EC, Quevedo FC, Neto FA, Rainho CA, Rogatto SR. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer. BMC Cancer 2006; 6:48 PMID:16512896; http://dx.doi.org/10.1186/1471-2407-6-48.
20. Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, et al. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 1995; 55:5195-9 PMID:7585573.
21. Hiraguri S, Godfrey T, Nakamura H, Graff J, Collins C, Shayesteh L, et al. Mechanisms of inactivation of E-cadherin in breast cancer cell lines. Cancer Res 1998; 58:1972-7 PMID:9581841.
22. Lombaerts M, van Wezel T, Philippo K, Dierssen JW, Zimmerman RM, Oosting J, et al. E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines. Br J Cancer 2006; 94:661-71 PMID:16495925.
23. Lind GE, Thorstensen L, Lovig T, Meling GI, Hamelin R, Rognum TO, et al. A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Mol Cancer 2004; 3:28 PMID:15476557; http://dx.doi.org/10.1186/1476-4598-3-28.
24. Zhong LP, Li J, Zhang CP, Zhu HG, Sun J, Zhang ZY. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients. Arch Oral Biol 2007; 52:740-7 PMID:17331461; http:// dx.doi.org/10.1016/j.archoralbio.2007.01.013.
25. Bukholm IK, Nesland JM, Borresen-Dale AL. Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [see comments]. J Pathol 2000; 190:15-9; PMID:10640987; http:// d x. doi. org/10. 100 2/(S I C I)1096-9896(200001)190:115::AID-PATH4893.0.CO;2-L.
26. Kowalski PJ, Rubin MA, Kleer CG. E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Res 2003; 5:217-22; PMID:14580257; http://dx.doi.org/10.1186/bcr651.
27. Chao YL, Shepard CR, Wells A. Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition. Mol Cancer 2010; 9:179; PMID:20609236; http://dx.doi.org/10.1186/1476-4598-9-179.
28. Schipper JH, Frixen UH, Behrens J, Unger A, Jahnke K, Birchmeier W. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res 1991; 51:6328-37; PMID:1933895.
29. Tse JC, Kalluri R. Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J Cell Biochem 2007; 101:816-29; PMID:17243120; http://dx.doi.org/10.1002/ jcb.21215.
30. Wells A, Yates C, Shepard CR. E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clin Exp Metastasis 2008; 25:621-8; PMID:18600305; http://dx.doi.org/10.1007/s10585-008-9167-1.
31. Alt-Holland A, Zhang W, Margulis A, Garlick JA. Microenvironmental control of premalignant disease: the role of intercellular adhesion in the progression of squamous cell carcinoma. Semin Cancer Biol 2005; 15:84-96; PMID:15652453; http://dx.doi. org/10.1016/j.semcancer.2004.08.007.
32. Kudo Y, Kitajjma S, Sato S, Miyauchi M, Ogawa I, Takata T. Establishment of an oral squamous cell carcinoma cell line with high invasive and p27 degradation activities from a lymph node metastasis. Oral Oncol 2003; 39:515-20; PMID:12747977; http://dx.doi. org/10.1016/S1368-8375(03)00015-0.
33. Kudo Y, Kitajima S, Ogawa I, Hiraoka M, Sargolzaei S, Keikhaee MR, et al. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin. Clin Cancer Res 2004; 10:5455-63; PMID:15328184; http://dx.doi. org/10.1158/1078-0432.CCR-04-0372.
34. Reinhold WC, Reimers MA, Maunakea AK, Kim S, Lababidi S, Scherf U, et al. Detailed DNA methylation profiles of the E-cadherin promoter in the NCI-60 cancer cells. Mol Cancer Ther 2007; 6:391-403; PMID:17272646; http://dx.doi.org/10.1158/1535-7163.MCT-06-0609.
35. Sen GL, Webster DE, Barragan DI, Chang HY, Khavari PA. Control of differentiation in a self-renewing mammalian tissue by the histone demethylase JMJD3. Genes Dev 2008; 22:1865-70; PMID:18628393; http://dx.doi.org/10.1101/gad.1673508.
36. Kondo Y, Shen L, Cheng AS, Ahmed S, Boumber Y, Charo C, et al. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat Genet 2008; 40:741-50; PMID:18488029; http://dx.doi.org/10.1038/ng.159.
37. Schlesinger Y, Straussman R, Keshet I, Farkash S, Hecht M, Zimmerman J, et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet 2007; 39:232-6; PMID:17200670; http://dx.doi. org/10.1038/ng1950.
38. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006; 125:315-26; PMID:16630819; http://dx.doi. org/10.1016/j.cell.2006.02.041.
39. Ohm JE, McGarvey KM, Yu X, Cheng L, Schuebel KE, Cope L, et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 2007; 39:237-42; PMID:17211412; http://dx.doi. org/10.1038/ng1972.
40. Duursma AM, Kedde M, Schrier M, le Sage C, Agami R. miR-148 targets human DNMT3b protein coding region. RNA 2008; 14:872-7; PMID:18367714; http://dx.doi.org/10.1261/rna.972008.
41. Pan W, Zhu S, Yuan M, Cui H, Wang L, Luo X, et al. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol 2010; 184:6773-81; PMID:20483747; http://dx.doi.org/10.4049/jimmunol.0904060.
42. Braconi C, Huang N, Patel T. MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes. Hepatology 2010; 51:881-90; PMID:20146264.
43. Dumont N, Wilson MB, Crawford YG, Reynolds PA, Sigaroudinia M, Tlsty TD. Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers. Proc Natl Acad Sci USA 2008; 105:14867-72; PMID:18806226; http://dx.doi.org/10.1073/ pnas.0807146105.
44. Eriksen JG, Steiniche T, Sogaard H, Overgaard J. Expression of integrins and E-cadherin in squamous cell carcinomas of the head and neck. APMIS 2004; 112:560-8; PMID:15601304; http://dx.doi. org/10.1111/j.1600-0463.2004.apm1120902.x.
45. Ansieau S, Bastid J, Doreau A, Morel AP, Bouchet BP, Thomas C, et al. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 2008; 14:79-89; PMID:18598946; http://dx.doi.org/10.1016/j. ccr.2008.06.005.
46. Weinberg RA. Twisted epithelial-mesenchymal transition blocks senescence. Nat Cell Biol 2008; 10:1021-3; PMID:18758491; http://dx.doi.org/10.1038/ ncb0908-1021.
47. Ateeq B, Unterberger A, Szyf M, Rabbani SA. Pharmacological inhibition of DNA methylation induces proinvasive and prometastatic genes in vitro and in vivo. Neoplasia 2008; 10:266-78; PMID:18320071.
48. Chik F, Szyf M. Effects of specific DNMT gene depletion on cancer cell transformation and breast cancer cell invasion; toward selective DNMT inhibitors. Carcinogenesis 2011; 32:224-32; PMID:20980350; http://dx.doi.org/10.1093/carcin/bgq221.
49. Frost P, Kerbel RS, Hunt B, Man S, Pathak S. Selection of metastatic variants with identifiable karyotypic changes from a nonmetastatic murine tumor after treatment with 2'-deoxy-5-azacytidine or hydroxyurea: implications for the mechanisms of tumor progression. Cancer Res 1987; 47:2690-5; PMID:2436755.
50. Yu Y, Zeng P, Xiong J, Liu Z, Berger SL, Merlino G. Epigenetic drugs can stimulate metastasis through enhanced expression of the pro-metastatic Ezrin gene. PLoS One 2010; 5:12710; PMID:20856924; http:// dx.doi.org/10.1371/journal.pone.0012710.
51. Widschwendter M, Fiegl H, Egle D, Mueller-Holzner E, Spizzo G, Marth C, et al. Epigenetic stem cell signature in cancer. Nat Genet 2007; 39:157-8; PMID:17200673; http://dx.doi.org/10.1038/ng1941.
52. Bracken AP, Dietrich N, Pasini D, Hansen KH, Helin K. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev 2006; 20:1123-36; PMID:16618801; http://dx.doi. org/10.1101/gad.381706.
53. Issa JP, Kantarjian HM. Targeting DNA methylation. Clin Cancer Res 2009; 15:3938-46; PMID:19509174; http://dx.doi.org/10.1158/1078-0432.CCR-08-2783.
54. Benton G, Crooke E, George J. Laminin-1 induces E-cadherin expression in 3-dimensional cultured breast cancer cells by inhibiting DNA methyltransferase 1 and reversing promoter methylation status. FASEB J 2009; 23:3884-95; PMID:19635753; http://dx.doi. org/10.1096/fj.08-128702.
55. Tseng CW, Lin CC, Chen CN, Huang HC, Juan HF. Integrative network analysis reveals active microRNAs and their functions in gastric cancer. BMC Syst Biol 2011; 5:99; PMID:21703006; http://dx.doi. org/10.1186/1752-0509-5-99.
56. Chen Y, Song Y, Wang Z, Yue Z, Xu H, Xing C, et al. Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance. J Gastrointest Surg 2010; 14:1170-9; PMID:20422307; http://dx.doi.org/10.1007/s11605-010-1202-2.
57. Deng S, Calin GA, Croce CM, Coukos G, Zhang L. Mechanisms of microRNA deregulation in human cancer. Cell Cycle 2008; 7:2643-6; PMID:18719391; http://dx.doi.org/10.4161/cc.7.17.6597.
58. Hanoun N, Delpu Y, Suriawinata AA, Bournet B, Bureau C, Selves J, et al. The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis. Clin Chem 2010; 56:1107-18; PMID:20431052; http://dx.doi. org/10.1373/clinchem.2010.144709.
59. Kumaki Y, Oda M, Okano M. QUMA: quantification tool for methylation analysis. Nucleic Acids Res 2008; 36:170-5; PMID:18487274; http://dx.doi. org/10.1093/nar/gkn294.
60. Carlson MW, Alt-Holland A, Egles C, Garlick JA. Three-dimensional tissue models of normal and diseased skin. Curr Protoc Cell Biol 2008; 19:9; PMID:19085986.